Vaccination and clozapine use: a systematic review and an analysis of the VAERS database.
Saved in:
| Title: | Vaccination and clozapine use: a systematic review and an analysis of the VAERS database. |
|---|---|
| Authors: | Aksar, Aslihan (AUTHOR), Lutz, Justina (AUTHOR), Wagner, Elias (AUTHOR), Strube, Wolfgang (AUTHOR), Luykx, Jurjen J. (AUTHOR), Hasan, Alkomiet (AUTHOR) |
| Source: | European Archives of Psychiatry & Clinical Neuroscience. Feb2025, Vol. 275 Issue 1, p141-162. 22p. |
| Subjects: | Vaccine safety, Drug monitoring, Vaccine effectiveness, Public health, Medical sciences |
| Abstract: | In the context of COVID-19 concerns related to the potential interactions between clozapine and vaccination arose. With the ultimate goal of deriving recommendations for clinical practice, we systematically reviewed the current evidence regarding altered vaccine effectiveness in clozapine-treated patients and safety aspects of vaccination, such as haematological changes and the impact of vaccines on clozapine blood levels, in clozapine-treated patients. A systematic PRISMA-conform literature search of four databases (PubMed, PsycINFO, EMBASE and Cochrane Library) complemented by a case-by-case analysis of the Vaccine Adverse Event Reporting System (VAERS) database was performed. We then systematically appraised the joint evidence and tried to derive recommendations for clinical practice. 14 records were included in this analysis. These records consisted of 5 original articles and 9 case reports. Among the original articles, two studies provided data on the association between clozapine use and antibody responses to vaccination, both indicating that clozapine use in schizophrenia may be associated with reduced levels of immunoglobulins. Additionally, three studies examined vaccine safety in clozapine-treated patients, with no clinically significant adverse effects directly attributable to the interplay between vaccinations and clozapine. VAERS Analysis encompassed 137 reports and showed no consistent evidence of an increased risk for clozapine blood level increases or adverse events. We found no evidence indicating that clozapine impairs the effectiveness of vaccines. Moreover, no serious safety concerns seem to apply when patients on clozapine are receiving vaccines. However, it is crucial to acknowledge that data on the interaction between clozapine and vaccines remain limited. [ABSTRACT FROM AUTHOR] |
| Copyright of European Archives of Psychiatry & Clinical Neuroscience is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 182842086 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Vaccination and clozapine use: a systematic review and an analysis of the VAERS database. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Aksar%2C+Aslihan%22">Aksar, Aslihan</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lutz%2C+Justina%22">Lutz, Justina</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wagner%2C+Elias%22">Wagner, Elias</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Strube%2C+Wolfgang%22">Strube, Wolfgang</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Luykx%2C+Jurjen+J%2E%22">Luykx, Jurjen J.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hasan%2C+Alkomiet%22">Hasan, Alkomiet</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22European+Archives+of+Psychiatry+%26+Clinical+Neuroscience%22">European Archives of Psychiatry & Clinical Neuroscience</searchLink>. Feb2025, Vol. 275 Issue 1, p141-162. 22p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Vaccine+safety%22">Vaccine safety</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+monitoring%22">Drug monitoring</searchLink><br /><searchLink fieldCode="DE" term="%22Vaccine+effectiveness%22">Vaccine effectiveness</searchLink><br /><searchLink fieldCode="DE" term="%22Public+health%22">Public health</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+sciences%22">Medical sciences</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: In the context of COVID-19 concerns related to the potential interactions between clozapine and vaccination arose. With the ultimate goal of deriving recommendations for clinical practice, we systematically reviewed the current evidence regarding altered vaccine effectiveness in clozapine-treated patients and safety aspects of vaccination, such as haematological changes and the impact of vaccines on clozapine blood levels, in clozapine-treated patients. A systematic PRISMA-conform literature search of four databases (PubMed, PsycINFO, EMBASE and Cochrane Library) complemented by a case-by-case analysis of the Vaccine Adverse Event Reporting System (VAERS) database was performed. We then systematically appraised the joint evidence and tried to derive recommendations for clinical practice. 14 records were included in this analysis. These records consisted of 5 original articles and 9 case reports. Among the original articles, two studies provided data on the association between clozapine use and antibody responses to vaccination, both indicating that clozapine use in schizophrenia may be associated with reduced levels of immunoglobulins. Additionally, three studies examined vaccine safety in clozapine-treated patients, with no clinically significant adverse effects directly attributable to the interplay between vaccinations and clozapine. VAERS Analysis encompassed 137 reports and showed no consistent evidence of an increased risk for clozapine blood level increases or adverse events. We found no evidence indicating that clozapine impairs the effectiveness of vaccines. Moreover, no serious safety concerns seem to apply when patients on clozapine are receiving vaccines. However, it is crucial to acknowledge that data on the interaction between clozapine and vaccines remain limited. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of European Archives of Psychiatry & Clinical Neuroscience is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=182842086 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00406-023-01729-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 22 StartPage: 141 Subjects: – SubjectFull: Vaccine safety Type: general – SubjectFull: Drug monitoring Type: general – SubjectFull: Vaccine effectiveness Type: general – SubjectFull: Public health Type: general – SubjectFull: Medical sciences Type: general Titles: – TitleFull: Vaccination and clozapine use: a systematic review and an analysis of the VAERS database. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Aksar, Aslihan – PersonEntity: Name: NameFull: Lutz, Justina – PersonEntity: Name: NameFull: Wagner, Elias – PersonEntity: Name: NameFull: Strube, Wolfgang – PersonEntity: Name: NameFull: Luykx, Jurjen J. – PersonEntity: Name: NameFull: Hasan, Alkomiet IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: Feb2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 09401334 Numbering: – Type: volume Value: 275 – Type: issue Value: 1 Titles: – TitleFull: European Archives of Psychiatry & Clinical Neuroscience Type: main |
| ResultId | 1 |